Form 4: AMETEK CAO Exercises Options, Sells Shares
Insider Transaction Report
AMETEK's Chief Administrative Officer, Ronald J. Oscher, exercised stock options and subsequently sold a portion of the acquired common stock on October 31, 2025.
Summary
- Ronald J. Oscher, Chief Administrative Officer of AMETEK INC/ (AME), engaged in transactions on October 31, 2025.
- He exercised stock options to acquire 14,310 shares of common stock at $63.37 per share.
- He also exercised stock options to acquire 11,980 shares of common stock at $85.45 per share.
- Following these acquisitions, he sold 26,290 shares of common stock at an average price of $200.0459 per share, with prices ranging from $200.00 to $200.19.
- The transactions were conducted under a Rule 10b5-1(c) plan.
- After these transactions, Oscher directly beneficially owns 40,226 shares of common stock, 910 shares indirectly through a 401k Plan, and 4,865 shares directly as Common Stock/Serp.
Sentiment
Score: 6
Explanation: The Chief Administrative Officer exercised stock options at significantly lower prices than the subsequent sale price, indicating a personal gain. The sale was conducted under a Rule 10b5-1 plan, which suggests a pre-scheduled transaction rather than one based on new, material non-public information. While a sale reduces insider ownership, the context of option exercise makes it a routine event.
Positives
- The exercise of stock options at $63.37 and $85.45, followed by a sale at an average of $200.0459, indicates a significant personal gain for the Chief Administrative Officer.
- The transaction was executed under a Rule 10b5-1(c) plan, suggesting a pre-scheduled sale not based on immediate, material non-public information.
Negatives
- An insider selling a significant number of shares, even if pre-planned, can sometimes be perceived negatively by the market as it reduces their direct equity stake.
Future Outlook
This filing is a report of historical insider transactions and does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This Form 4 filing details specific insider transactions and does not provide broader industry context or trends.
Stakeholder Impact
- Shareholders: The sale of shares by a key executive, even under a 10b5-1 plan, might lead to minor concerns about insider sentiment, though the pre-planned nature mitigates significant negative interpretation. The executive still retains a substantial number of shares.
Key Dates
| Date | Description |
|---|---|
| 05/09/2020 | Start date for exercisability of 11,980 stock options in three equal annual installments. |
| 03/20/2021 | Start date for exercisability of 14,310 stock options in three equal annual installments. |
| 10/31/2025 | Date of reported transactions (option exercises and stock sale). |
| 11/03/2025 | Signature date of the reporting person's attorney-in-fact. |
| 05/09/2029 | Expiration date for 11,980 stock options. |
| 03/20/2030 | Expiration date for 14,310 stock options. |
Recommendation
holdThis Form 4 reports routine insider transactions involving the exercise of stock options and subsequent sale of shares under a pre-arranged 10b5-1 plan. Such transactions are common for executive compensation and personal financial planning and do not typically signal a change in the company's fundamental outlook. The insider realized a profit from the option exercises, which is a positive for the individual, but the sale itself does not provide new information to warrant a change in investment recommendation for the stock.
Keywords
AMETEK, AME, Insider Trading, Form 4, Stock Options, Share Sale, Ronald J. Oscher, Chief Administrative Officer, Equity Transaction, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.